197 related articles for article (PubMed ID: 34729692)
1. Recent Advances in the Role of Diet in Bone and Mineral Disorders in Chronic Kidney Disease.
Gutiérrez OM
Curr Osteoporos Rep; 2021 Dec; 19(6):574-579. PubMed ID: 34729692
[TBL] [Abstract][Full Text] [Related]
2. Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.
Stremke ER; Biruete A; Hill Gallant KM
Curr Osteoporos Rep; 2020 Jun; 18(3):247-253. PubMed ID: 32240477
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of randomized controlled trials of tonifying kidney and strengthen bone therapy on nondialysis patients with chronic kidney disease-mineral and bone disorder.
Wu G; Li L; Wu Z
Medicine (Baltimore); 2023 Jun; 102(25):e34044. PubMed ID: 37352066
[TBL] [Abstract][Full Text] [Related]
4. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway.
Shen J; Liu Y; Wang Q; Chen H; Hu Y; Guo X; Liu X; Li Y
J Ethnopharmacol; 2023 Oct; 314():116590. PubMed ID: 37207881
[TBL] [Abstract][Full Text] [Related]
5. Effects of Plant-Based Protein Consumption on Kidney Function and Mineral Bone Disorder Outcomes in Adults With Stage 3-5 Chronic Kidney Disease: A Systematic Review.
Burstad KM; Cladis DP; Wiese GN; Butler M; Hill Gallant KM
J Ren Nutr; 2023 Nov; 33(6):717-730. PubMed ID: 37116624
[TBL] [Abstract][Full Text] [Related]
6. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
[TBL] [Abstract][Full Text] [Related]
7. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
8. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
Biruete A; Srinivasan S; O'Neill KD; Vorland CJ; Hill Gallant KM; Cai W; Uribarri J; Johnston N; Allen MR; Chen NX; Moe SM
Am J Nephrol; 2020; 51(5):381-389. PubMed ID: 32146472
[TBL] [Abstract][Full Text] [Related]
9. Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).
Rodriguez M; Aguilera-Tejero E
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513703
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.
Hanudel MR; Salusky IB
Curr Osteoporos Rep; 2017 Jun; 15(3):198-206. PubMed ID: 28455644
[TBL] [Abstract][Full Text] [Related]
11. Management of phosphorus load in CKD patients.
Taketani Y; Koiwa F; Yokoyama K
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):27-36. PubMed ID: 27896453
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
Chuang SH; Wong HC; Vathsala A; Lee E; How PP
Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Dietary Interventions on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Rysz J; Franczyk B; Rokicki R; Gluba-Brzózka A
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34208727
[TBL] [Abstract][Full Text] [Related]
15. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.
Meza K; Biswas S; Zhu YS; Gajjar A; Perelstein E; Kumar J; Akchurin O
Pediatr Nephrol; 2021 Jun; 36(6):1579-1587. PubMed ID: 33387018
[TBL] [Abstract][Full Text] [Related]
17. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
[TBL] [Abstract][Full Text] [Related]
18. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis.
Liu BH; Chong FL; Yuan CC; Liu YL; Yang HM; Wang WW; Fang QJ; Wu W; Wang MZ; Tu Y; Wan ZY; Wan YG; Wu GW
Front Pharmacol; 2020; 11():586725. PubMed ID: 33708111
[No Abstract] [Full Text] [Related]
20. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH
Nephrol Dial Transplant; 2009 Aug; 24(8):2371-7. PubMed ID: 19258382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
